39th ACS National Medicinal Chemistry Symposium 2026

Meet Novalix at the 39th ACS National Medicinal Chemistry Symposium 2026 in Atlanta, GA!

This event organized by the American Chemical Society (ACS) brings together medicinal chemists from industry, academia, regulatory agencies and private research institutions to explore presentations spanning all chemistry disciplines, symposia, and an exhibition showcasing the latest tools.

ACS meetings enable chemistry professionals to meet to share ideas and advance scientific and technical knowledge.

Luc Van Hijfte, President of the EFMC, and Senior advisor Drug Discovery at Novalix, will attend the ACS Symposium, together with Timothy Keefe, Director Business Development.

A Quest for Novel Series of PI4KIIIß Inhibitors using Novalix DEL Proprietary Library & Generative AI

We are proud to share that Dr Van Hijfte will present a new poster on how DEL screening enabled us to successfully identify promising starting point to inhibit selectively PI4KB over PI4KA. Preliminary SAR expansion has led to significant improvement of compound potency.

Novalix booth No.30

Meet the Novalix team at our booth #30 for more details, and discuss about your drug discovery programs.

Bringing deep expertise in chemistry, medicinal chemistry, pharmacology, DMPK, and biophysics, our highly integrated approach is designed to create real value for our partners.

Contact us to know more about our services, and to explore how Novalix can support your drug discovery challenges from the earliest stages to candidate selection!